Advertisement
Screener

ENDRA LIFE SCIENCES INC. (NDRA) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

ENDRA LIFE SCIENCES INC. Research and Development Expense

ENDRA LIFE SCIENCES INC. (NDRA) reported Research and Development Expense of $233.66 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14

  • ENDRA LIFE SCIENCES INC. research and development expense for the quarter ending 2026-06-30 was $233.66K, a 38.68% decline year-over-year.
  • ENDRA LIFE SCIENCES INC. research and development expense for the quarter ending 2026-03-31 was $776.41K, a 46.86% increase year-over-year.
  • ENDRA LIFE SCIENCES INC. research and development expense for the quarter ending 2025-12-31 was $508.14K, a 20.35% decline year-over-year.
  • ENDRA LIFE SCIENCES INC. research and development expense for the quarter ending 2025-09-30 was $432.11K, a 45.61% decline year-over-year.
  • ENDRA LIFE SCIENCES INC. research and development expense for fiscal 2025 was $1.85M, a 42.01% decline from fiscal 2024.
  • ENDRA LIFE SCIENCES INC. research and development expense for fiscal 2024 was $3.19M, a 36.24% decline from fiscal 2023.
  • ENDRA LIFE SCIENCES INC. research and development expense for fiscal 2023 was $5.00M, a 23.66% decline from fiscal 2022.
  • ENDRA LIFE SCIENCES INC. research and development expense for fiscal 2022 was $6.55M, a 19.55% increase from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 12 month
2026-06-30$233.66K
10-Q · filed 2026-08-14
$1.01M
10-Q · filed 2026-08-14
$1.52M
derived: sum of 3 quarters · filed 2026-08-14
$1.95M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$776.41K
10-Q · filed 2026-05-15
$1.28M
derived: sum of 2 quarters · filed 2026-05-15
$1.72M
derived: sum of 3 quarters · filed 2026-05-15
$2.10M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$508.14K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$940.25K
derived: sum of 2 quarters · filed 2026-03-31
$1.32M
derived: sum of 3 quarters · filed 2026-08-14
$1.85M
10-K · filed 2026-03-31
2025-09-30$432.11K
10-Q · filed 2025-11-14
$813.17K
derived: sum of 2 quarters · filed 2026-08-14
$1.34M
10-Q · filed 2025-11-14
$1.98M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$381.06K
10-Q · filed 2026-08-14
$909.75K
10-Q · filed 2026-08-14
$1.55M
derived: sum of 3 quarters · filed 2026-08-14
$2.34M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$528.68K
10-Q · filed 2026-05-15
$1.17M
derived: sum of 2 quarters · filed 2026-05-15
$1.96M
derived: sum of 3 quarters · filed 2026-05-15
$2.68M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$637.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$1.43M
derived: sum of 2 quarters · filed 2026-03-31
$2.15M
derived: sum of 3 quarters · filed 2026-03-31
$3.19M
10-K · filed 2026-03-31
2024-09-30$794.44K
10-Q · filed 2025-11-14
$1.51M
derived: sum of 2 quarters · filed 2025-11-14
$2.55M
10-Q · filed 2025-11-14
$3.13M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$716.37K
10-Q · filed 2025-08-14
$1.76M
10-Q · filed 2025-08-14
$2.34M
derived: sum of 3 quarters · filed 2025-08-14
$3.97M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$1.04M
10-Q · filed 2025-05-15
$1.62M
derived: sum of 2 quarters · filed 2025-05-15
$3.25M
derived: sum of 3 quarters · filed 2025-05-15
$4.65M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$579.35K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07
$2.21M
derived: sum of 2 quarters · filed 2025-04-07
$3.61M
derived: sum of 3 quarters · filed 2025-04-07
$5.00M
10-K/A · filed 2025-04-07
2023-09-30$1.63M
10-Q/A · filed 2024-11-21
$3.03M
derived: sum of 2 quarters · filed 2024-11-21
$4.42M
10-Q/A · filed 2024-11-21
$6.09M
derived: sum of 4 quarters · filed 2024-11-21
2023-06-30$1.40M
10-Q · filed 2024-08-14
$2.79M
10-Q · filed 2024-08-14
$4.45M
derived: sum of 3 quarters · filed 2024-08-14
$6.29M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$1.39M
10-Q · filed 2024-05-14
$3.05M
derived: sum of 2 quarters · filed 2024-05-14
$4.88M
derived: sum of 3 quarters · filed 2024-05-14
$6.73M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$1.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$3.49M
derived: sum of 2 quarters · filed 2024-03-28
$5.34M
derived: sum of 3 quarters · filed 2024-03-28
$6.55M
10-K · filed 2024-03-28
2022-09-30$1.83M
10-Q · filed 2023-11-14
$3.68M
derived: sum of 2 quarters · filed 2023-11-14
$4.89M
10-Q · filed 2023-11-14
$6.31M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$1.85M
10-Q · filed 2023-08-14
$3.06M
10-Q · filed 2023-08-14
$4.48M
derived: sum of 3 quarters · filed 2023-08-14
$5.66M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$1.21M
10-Q · filed 2023-05-15
$2.64M
derived: sum of 2 quarters · filed 2023-05-15
$3.81M
derived: sum of 3 quarters · filed 2023-05-15
$5.55M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$1.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$2.60M
derived: sum of 2 quarters · filed 2023-03-16
$4.34M
derived: sum of 3 quarters · filed 2023-03-16
$5.48M
10-K · filed 2023-03-16
2021-09-30$1.17M
10-Q · filed 2022-11-14
$2.92M
derived: sum of 2 quarters · filed 2022-11-14
$4.06M
10-Q · filed 2022-11-14
$5.20M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$1.74M
10-Q · filed 2022-08-15
$2.89M
10-Q · filed 2022-08-15
$4.03M
derived: sum of 3 quarters · filed 2022-08-15
$5.80M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$1.14M
10-Q · filed 2022-05-12
$2.28M
derived: sum of 2 quarters · filed 2022-05-12
$4.05M
derived: sum of 3 quarters · filed 2022-05-12
$5.54M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$2.91M
derived: sum of 2 quarters · filed 2022-03-30
$4.40M
derived: sum of 3 quarters · filed 2022-03-30
$5.92M
10-K · filed 2022-03-30
2020-09-30$1.77M
10-Q · filed 2021-11-15
$3.26M
derived: sum of 2 quarters · filed 2021-11-15
$4.77M
10-Q · filed 2021-11-15
$6.80M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$1.49M
10-Q · filed 2021-08-12
$3.01M
10-Q · filed 2021-08-12
$5.03M
derived: sum of 3 quarters · filed 2021-08-12
$6.50M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$1.52M
10-Q · filed 2021-05-17
$3.55M
derived: sum of 2 quarters · filed 2021-05-17
$5.01M
derived: sum of 3 quarters · filed 2021-05-17
$6.32M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$2.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
$3.50M
derived: sum of 2 quarters · filed 2021-03-25
$4.80M
derived: sum of 3 quarters · filed 2021-03-25
$6.57M
10-K · filed 2021-03-25
2019-09-30$1.47M
10-Q · filed 2020-11-16
$2.77M
derived: sum of 2 quarters · filed 2020-11-16
$4.55M
10-Q · filed 2020-11-16
$5.60M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$1.30M
10-Q · filed 2020-08-14
$1.30M
10-Q · filed 2019-08-08
$3.08M
10-Q · filed 2020-08-14
$4.13M
derived: sum of 3 quarters · filed 2020-08-14
$5.29M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$1.77M
10-Q · filed 2020-05-14
$2.82M
derived: sum of 2 quarters · filed 2020-05-14
$3.99M
derived: sum of 3 quarters · filed 2020-05-14
$4.83M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
$2.21M
derived: sum of 2 quarters · filed 2020-03-26
$3.05M
derived: sum of 3 quarters · filed 2020-03-26
$4.72M
10-K · filed 2020-03-26
2018-09-30$1.16M
10-Q · filed 2019-11-13
$2.00M
derived: sum of 2 quarters · filed 2019-11-13
$3.67M
10-Q · filed 2019-11-13
$5.03M
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30$839.76K
10-Q · filed 2019-08-08
$2.51M
10-Q · filed 2019-08-08
$3.87M
derived: sum of 3 quarters · filed 2019-08-08
$4.17M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$1.67M
10-Q · filed 2019-05-14
$3.03M
derived: sum of 2 quarters · filed 2019-05-14
$3.33M
derived: sum of 3 quarters · filed 2019-05-14
$3.50M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$1.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11
$1.66M
derived: sum of 2 quarters · filed 2019-03-11
$1.84M
derived: sum of 3 quarters · filed 2019-03-11
$1.93M
10-K · filed 2019-03-11
2017-09-30$300.53K
10-Q · filed 2018-11-05
$475.25K
derived: sum of 2 quarters · filed 2018-11-05
$571.07K
10-Q · filed 2018-11-05
$730.03K
derived: sum of 4 quarters · filed 2018-11-05
2017-06-30$174.72K
10-Q · filed 2018-08-13
$174.73K
10-Q · filed 2017-08-07
$270.54K
10-Q · filed 2018-08-13
$270.54K
10-Q · filed 2017-08-07
$429.50K
derived: sum of 3 quarters · filed 2018-08-13
$567.04K
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31$95.81K
10-Q · filed 2018-05-15
$254.77K
derived: sum of 2 quarters · filed 2018-05-15
$392.31K
derived: sum of 3 quarters · filed 2018-05-15
$495.95K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$158.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20
$296.50K
derived: sum of 2 quarters · filed 2018-03-20
$400.14K
derived: sum of 3 quarters · filed 2018-03-20
$495.38K
10-K · filed 2018-03-20
2016-09-30$137.54K
10-Q · filed 2017-11-14
$241.18K
derived: sum of 2 quarters · filed 2017-11-14
$336.42K
10-Q · filed 2017-11-14
2016-06-30$103.64K
10-Q · filed 2017-08-07
$198.88K
10-Q · filed 2017-08-07
2016-03-31$198.88K
10-Q · filed 2017-08-07
$95.24K
10-Q · filed 2017-06-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRIDEX CORP (IRIX)United States$0.011B
Nuwellis, Inc. (NUWE)United States$0.003B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B